Interpace Biosciences, Inc. filed its 10-K on Mar 27, 2023 for the period ending Dec 31, 2022. In this report its auditor, EisnerAmper LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | -5.36% |
|
-3.09% | +7.41% |
1st Jan change | Capi. | |
---|---|---|
+7.41% | 5.08M | |
-15.51% | 5.27B | |
-1.55% | 1.16B |
- Stock Market
- Equities
- IDXG Stock
- News Interpace Biosciences, Inc.
- Interpace Biosciences, Inc. Auditor Raises 'Going Concern' Doubt